JP5719293B2 - 標的化ニトロキシド剤 - Google Patents

標的化ニトロキシド剤 Download PDF

Info

Publication number
JP5719293B2
JP5719293B2 JP2011518936A JP2011518936A JP5719293B2 JP 5719293 B2 JP5719293 B2 JP 5719293B2 JP 2011518936 A JP2011518936 A JP 2011518936A JP 2011518936 A JP2011518936 A JP 2011518936A JP 5719293 B2 JP5719293 B2 JP 5719293B2
Authority
JP
Japan
Prior art keywords
cells
xjb
compound
mmol
nitroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011518936A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011528378A (ja
JP2011528378A5 (enExample
Inventor
ウィプフ，ピーター
フランツ，マリー・セリーヌ
Original Assignee
ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション
ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション, ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション filed Critical ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション
Publication of JP2011528378A publication Critical patent/JP2011528378A/ja
Publication of JP2011528378A5 publication Critical patent/JP2011528378A5/ja
Application granted granted Critical
Publication of JP5719293B2 publication Critical patent/JP5719293B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94—Oxygen atom, e.g. piperidine N-oxide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2011518936A 2008-07-17 2009-07-17 標的化ニトロキシド剤 Expired - Fee Related JP5719293B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US8158508P 2008-07-17 2008-07-17
US61/081,585 2008-07-17
US15856909P 2009-03-09 2009-03-09
US61/158,569 2009-03-09
US17857009P 2009-05-15 2009-05-15
US61/178,570 2009-05-15
PCT/US2009/051004 WO2010009405A2 (en) 2008-07-17 2009-07-17 Targeted nitroxide agents

Publications (3)

Publication Number Publication Date
JP2011528378A JP2011528378A (ja) 2011-11-17
JP2011528378A5 JP2011528378A5 (enExample) 2012-08-30
JP5719293B2 true JP5719293B2 (ja) 2015-05-13

Family

ID=41551032

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011518936A Expired - Fee Related JP5719293B2 (ja) 2008-07-17 2009-07-17 標的化ニトロキシド剤

Country Status (11)

Country Link
US (8) US8288551B2 (enExample)
EP (1) EP2328875B1 (enExample)
JP (1) JP5719293B2 (enExample)
CN (1) CN102159553B (enExample)
AU (1) AU2009270740B8 (enExample)
CA (1) CA2768183C (enExample)
DK (1) DK2328875T3 (enExample)
ES (1) ES2527958T3 (enExample)
PL (1) PL2328875T3 (enExample)
PT (1) PT2328875E (enExample)
WO (1) WO2010009405A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718603B1 (en) * 2006-01-06 2010-05-18 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Selective targeting agents for mitochondria
WO2010009389A1 (en) * 2008-07-17 2010-01-21 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Use of targeted nitroxide agents in preventing, mitigating and treating radiation injury
WO2010009327A1 (en) 2008-07-17 2010-01-21 University Of Pittsburgh Of The Commonwealth System Of Higher Education Compounds for the treatment of pathologies associated with aging and degenerative disorders
AU2009270740B8 (en) 2008-07-17 2015-07-09 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Targeted nitroxide agents
WO2010141824A2 (en) * 2009-06-05 2010-12-09 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Use of targeted nitroxide agents in bone healing
EP2461747B1 (en) * 2009-08-06 2019-03-06 Peter Theophilos Banos Device for monitoring the effects of cellular stress and damage resulting from radiation exposure
US8778969B2 (en) 2009-11-07 2014-07-15 Peter H Proctor Nitrone, nitroso, and nitroxide spintraps and spin labels and their hydroxylamines
US9217000B2 (en) 2011-02-18 2015-12-22 Univerisyt of Pittsburgh—of the Commonwealth System of Higher Education Targeted nitroxide agents
US9200035B2 (en) 2011-10-21 2015-12-01 University of Pittsburgh—of the Commonwealth System of Higher Education Bifunctional compounds
CN104530424B (zh) * 2014-11-28 2017-03-29 武汉工程大学 异氮杂茚氧化氮自由基改性聚苯胺及其合成方法和用途
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation
CN106267223A (zh) * 2015-05-11 2017-01-04 华东理工大学 一种基于氧自由基的靶向功能材料及其应用
US10450289B2 (en) 2015-06-08 2019-10-22 University of Pittsburgh—of the Commonwealth System of Higher Education Substituted β-lapachones for treating cancer
WO2017004073A1 (en) * 2015-06-29 2017-01-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Bisnitroxides
US10028943B2 (en) 2015-07-05 2018-07-24 Peter Herbert Proctor Method for treatment of radiologically-dense breasts
WO2017040537A1 (en) 2015-08-31 2017-03-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compounds for bone healing
US9676738B2 (en) 2015-10-14 2017-06-13 University of Pittsburgh—of the Commonwealth System of Higher Education Antifibrotic effects of oxetanyl sulfoxides
WO2018071761A1 (en) * 2016-10-13 2018-04-19 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Mitochondrially targeted parp inhibitor, and uses thereof
WO2021021699A1 (en) 2019-07-26 2021-02-04 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Targeted nitroxide compounds and their use in treating ferroptosis-related diseases
US12128038B2 (en) 2020-12-29 2024-10-29 University of Pittsburgh—of the Commonwealth System of Higher Education Method of treatment of organic acidemias and other mitochondria defects or deficiencies
CN116789888B (zh) * 2023-05-04 2025-11-18 浙江大学 一种能够减轻器官缺血再灌注损伤的抗自由基聚合物及其制备方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587388A (en) 1992-12-02 1996-12-24 Lucky Limited Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
JP2008533031A (ja) * 2005-03-09 2008-08-21 ニトロメッド インコーポレーティッド アンギオテンシンｉｉアンタゴニストの有機酸化窒素増強塩、組成物および使用法
US20070161544A1 (en) * 2006-01-06 2007-07-12 Peter Wipf Selective targeting agents for mitcochondria
US7528174B2 (en) * 2006-01-06 2009-05-05 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Selective targeting agents for mitochondria
US7718603B1 (en) * 2006-01-06 2010-05-18 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Selective targeting agents for mitochondria
AU2009270740B8 (en) * 2008-07-17 2015-07-09 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Targeted nitroxide agents
WO2010009327A1 (en) * 2008-07-17 2010-01-21 University Of Pittsburgh Of The Commonwealth System Of Higher Education Compounds for the treatment of pathologies associated with aging and degenerative disorders
WO2010009389A1 (en) * 2008-07-17 2010-01-21 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Use of targeted nitroxide agents in preventing, mitigating and treating radiation injury
US20120207687A1 (en) * 2011-01-14 2012-08-16 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Topical formulations of targeted nitroxide agents
US9217000B2 (en) 2011-02-18 2015-12-22 Univerisyt of Pittsburgh—of the Commonwealth System of Higher Education Targeted nitroxide agents

Also Published As

Publication number Publication date
CA2768183A1 (en) 2010-01-21
JP2011528378A (ja) 2011-11-17
WO2010009405A3 (en) 2010-05-14
CN102159553B (zh) 2016-02-17
US20100035869A1 (en) 2010-02-11
EP2328875A4 (en) 2012-03-21
US20180298054A1 (en) 2018-10-18
US9216976B2 (en) 2015-12-22
AU2009270740B8 (en) 2015-07-09
US20200317730A1 (en) 2020-10-08
US9890192B2 (en) 2018-02-13
AU2009270740B2 (en) 2015-01-22
US20230144767A1 (en) 2023-05-11
DK2328875T3 (en) 2015-02-02
HK1157344A1 (zh) 2012-06-29
PL2328875T3 (pl) 2015-04-30
US20140378444A1 (en) 2014-12-25
CA2768183C (en) 2018-02-20
EP2328875B1 (en) 2014-10-15
WO2010009405A2 (en) 2010-01-21
EP2328875A2 (en) 2011-06-08
US20160137692A1 (en) 2016-05-19
WO2010009405A9 (en) 2010-03-25
US20130102626A1 (en) 2013-04-25
US8609850B2 (en) 2013-12-17
CN102159553A (zh) 2011-08-17
AU2009270740A1 (en) 2010-01-21
ES2527958T3 (es) 2015-02-02
US10526368B2 (en) 2020-01-07
PT2328875E (pt) 2015-02-04
US8288551B2 (en) 2012-10-16
US20210371460A1 (en) 2021-12-02

Similar Documents

Publication Publication Date Title
JP5719293B2 (ja) 標的化ニトロキシド剤
US8822541B2 (en) Use of targeted nitroxide agents in mitigating or treating radiation injury
US9732105B2 (en) Targeted nitroxide agents
US9402839B2 (en) Selective targeting agents for mitochondria
US20070161544A1 (en) Selective targeting agents for mitcochondria
US20190210969A1 (en) Intraesophageal administration of targeted nitroxide agents for protection against ionizing irradiation-induced esophagitis
US8748369B2 (en) Use of targeted nitroxide agents in bone healing
HK1157344B (en) Targeted nitroxide agents

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120712

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120712

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20131226

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140107

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140407

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140414

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140502

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140513

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140606

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140613

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140707

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150220

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150320

R150 Certificate of patent or registration of utility model

Ref document number: 5719293

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees